Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,129 across all filing types
Latest filing 2022-11-21 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
111年第3季財務報告書 — 202202_1707_AIA.pdf
Regulatory Filings
2022-11-21 Chinese
111年第3季財務報告書 — 202202_1707_AI1.pdf
Regulatory Filings
2022-11-21 Chinese
111年第3季財務報告書 — 202201_1707_AIA.pdf
Regulatory Filings
2022-11-21 Chinese
111年第3季財務報告書 — 202201_1707_AI1.pdf
Regulatory Filings
2022-11-21 Chinese
111年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 葡萄王, providing information about fund loans and endorsement guarantees for the current and previous months, with zero balances reported. The content is very short (602 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial results. It is a regulatory disclosure of specific financial information, likely a routine compliance filing rather than a full report. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-09 Chinese
111年10月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report for a company named 葡萄王 for the month of October in 民國111年 (which corresponds to 2022). It contains monthly and cumulative revenue figures with percentage changes compared to the previous year. The document is short (772 characters) and provides financial data but does not contain comprehensive financial statements or detailed analysis. It appears to be a periodic revenue update rather than a full interim or annual report. Given the nature of the data (monthly revenue summary) and the absence of detailed financial statements or management discussion, this fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth required for an Interim Report (IR) or Annual Report (10-K).
2022-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.